Showing results (241-250 of 276) with videos related to
Sort By:
Pageof 28
Endocrine|September 18, 2007
Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell linesS Hoffmann, A Burchert, A Wunderlich, et al.Pancreas|November 15, 2000
Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?B Gerdes, D K Bartsch, A Ramaswamy, et al.Digestion|October 12, 2000
Low frequency of p16(INK4a) alterations in insulinomasD K Bartsch, M Kersting, A Wild, et al.Annals of Surgery|July 22, 1998
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreasD Bartsch, D Bastian, P Barth, et al.Journal of Clinical Gastroenterology|August 1, 1990
Intramural pancreatic pseudocyst in the gastric wall: diagnosis by sonography and ultrasound-guided punctureI Koop, H Mönnikes, C Fehmann, et al.World Journal of Surgery|October 19, 2000
Management of nonfunctioning islet cell carcinomasD K Bartsch, T Schilling, A Ramaswamy, et al.World Journal of Surgery|January 22, 2008
Graft-dependent renal hyperparathyroidism despite successful kidney transplantationK Schlosser, M Rothmund, K Maschuw, et al.Langenbeck'S Archives of Surgery|October 21, 2006
Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors--a novel antiproliferative/antiangiogenic strategy in thyroid cancerS Hoffmann, S Gläser, A Wunderlich, et al.World Journal of Surgery|June 20, 1998
Amitogenic alginates: key to first clinical application of microencapsulation technologyC Hasse, A Zielke, G Klöck, et al.Cancer|July 18, 2000
Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer GroupS Hölzer, C Reiners, K Mann, et al.Pageof 28